Mark Brosius Sells 175 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 175 shares of the stock in a transaction on Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the sale, the senior vice president now owns 883 shares in the company, valued at approximately $343,628.28. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Mark Brosius also recently made the following trade(s):

• On Wednesday, May 15th, Mark Brosius sold 175 shares of Intuitive Surgical stock. The stock was sold at an average price of $387.22, for a total value of $67,763.50.
• On Thursday, March 7th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.30, for a total value of $77,086.80.
• On Tuesday, March 5th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The stock was sold at an average price of $400.00, for a total value of $78,400.00.
• On Friday, February 16th, Mark Brosius sold 32 shares of Intuitive Surgical stock. The stock was sold at an average price of $378.29, for a total value of $12,105.28.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $1.41 during mid-day trading on Thursday, reaching $397.98. 541,433 shares of the company were exchanged, compared to its average volume of 1,558,761. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock has a market capitalization of $141.16 billion, a PE ratio of 71.89, a PEG ratio of 4.92 and a beta of 1.39. The business has a 50 day simple moving average of $384.75 and a two-hundred day simple moving average of $356.37.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period last year, the company earned $1.00 earnings per share. The firm’s revenue was up 11.5% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Robert W. Baird lowered their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Citigroup increased their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Piper Sandler increased their target price on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. BTIG Research increased their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Mizuho raised their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in the stock. Delos Wealth Advisors LLC increased its holdings in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Baystate Wealth Management LLC increased its holdings in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC increased its holdings in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares in the last quarter. Able Wealth Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Atticus Wealth Management LLC increased its holdings in Intuitive Surgical by 85.4% in the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 41 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.